Cargando…
Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis
BACKGROUND: More accurate predictive and prognostic biomarkers for patients with colorectal cancer (CRC) primaries or colorectal liver metastasis (CLM) are needed. Outside clinical trials, the translational integration of emerging pathways and novel techniques should facilitate exploration of biomar...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928276/ https://www.ncbi.nlm.nih.gov/pubmed/27357108 http://dx.doi.org/10.1186/s12967-016-0951-4 |
_version_ | 1782440407389437952 |
---|---|
author | Søreide, Kjetil Watson, Martin M. Lea, Dordi Nordgård, Oddmund Søreide, Jon Arne Hagland, Hanne R. |
author_facet | Søreide, Kjetil Watson, Martin M. Lea, Dordi Nordgård, Oddmund Søreide, Jon Arne Hagland, Hanne R. |
author_sort | Søreide, Kjetil |
collection | PubMed |
description | BACKGROUND: More accurate predictive and prognostic biomarkers for patients with colorectal cancer (CRC) primaries or colorectal liver metastasis (CLM) are needed. Outside clinical trials, the translational integration of emerging pathways and novel techniques should facilitate exploration of biomarkers for improved staging and prognosis. METHODS: An observational study exploring predictive and prognostic biomarkers in a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastases. Long-term outcomes will be cancer-specific survival, recurrence-free survival and overall survival at 5 years from diagnosis. Beyond routine clinicopathological and anthropometric characteristics and laboratory and biochemistry results, the project allows for additional blood samples and fresh-frozen tumour and normal tissue for investigation of circulating tumour cells (CTCs) and novel biomarkers (e.g. immune cells, microRNAs etc.). Tumour specimens will be investigated by immunohistochemistry in full slides. Extracted DNA/RNA will be analysed for genomic markers using specific PCR techniques and next-generation sequencing (NGS) panels. Flow cytometry will be used to characterise biomarkers in blood. Collaboration is open and welcomed, with particular interest in mutual opportunities for validation studies. STATUS AND PERSPECTIVES: The project is ongoing and recruiting at an expected rate of 120–150 patients per year, since January 2013. A project on circulating tumour cells (CTCs) has commenced, with analysis being prepared. Investigating molecular classes beyond the TNM staging is under way, including characteristics of microsatellite instability (MSI) and elevated microsatellite alterations in selected tetranucleotides (EMAST). Hot spot panels for known mutations in CRC are being investigated using NGS. Immune-cell characteristics are being performed by IHC and flow cytometry in tumour and peripheral blood samples. The project has ethical approval (REK Helse Vest, #2012/742), is financially supported with a Ph.D.-Grant (EMAST project; Folke Hermansen Cancer Fund) and a CTC-project (Norwegian Research Council; O. Nordgård). The ACROBATICC clinical and molecular biobank repository will serve as a long-term source for novel exploratory analysis and invite collaborators for mutual validation of promising biomarker results. The project aims to generate results that can help better discern prognostic groups in stage II/III cancers; explore prognostic and predictive biomarkers, and help detail the biology of colorectal liver metastasis for better patient selection and tailored treatment. The project is registered at http://www.ClinicalTrials.gov NCT01762813. |
format | Online Article Text |
id | pubmed-4928276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49282762016-06-30 Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis Søreide, Kjetil Watson, Martin M. Lea, Dordi Nordgård, Oddmund Søreide, Jon Arne Hagland, Hanne R. J Transl Med Protocol BACKGROUND: More accurate predictive and prognostic biomarkers for patients with colorectal cancer (CRC) primaries or colorectal liver metastasis (CLM) are needed. Outside clinical trials, the translational integration of emerging pathways and novel techniques should facilitate exploration of biomarkers for improved staging and prognosis. METHODS: An observational study exploring predictive and prognostic biomarkers in a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastases. Long-term outcomes will be cancer-specific survival, recurrence-free survival and overall survival at 5 years from diagnosis. Beyond routine clinicopathological and anthropometric characteristics and laboratory and biochemistry results, the project allows for additional blood samples and fresh-frozen tumour and normal tissue for investigation of circulating tumour cells (CTCs) and novel biomarkers (e.g. immune cells, microRNAs etc.). Tumour specimens will be investigated by immunohistochemistry in full slides. Extracted DNA/RNA will be analysed for genomic markers using specific PCR techniques and next-generation sequencing (NGS) panels. Flow cytometry will be used to characterise biomarkers in blood. Collaboration is open and welcomed, with particular interest in mutual opportunities for validation studies. STATUS AND PERSPECTIVES: The project is ongoing and recruiting at an expected rate of 120–150 patients per year, since January 2013. A project on circulating tumour cells (CTCs) has commenced, with analysis being prepared. Investigating molecular classes beyond the TNM staging is under way, including characteristics of microsatellite instability (MSI) and elevated microsatellite alterations in selected tetranucleotides (EMAST). Hot spot panels for known mutations in CRC are being investigated using NGS. Immune-cell characteristics are being performed by IHC and flow cytometry in tumour and peripheral blood samples. The project has ethical approval (REK Helse Vest, #2012/742), is financially supported with a Ph.D.-Grant (EMAST project; Folke Hermansen Cancer Fund) and a CTC-project (Norwegian Research Council; O. Nordgård). The ACROBATICC clinical and molecular biobank repository will serve as a long-term source for novel exploratory analysis and invite collaborators for mutual validation of promising biomarker results. The project aims to generate results that can help better discern prognostic groups in stage II/III cancers; explore prognostic and predictive biomarkers, and help detail the biology of colorectal liver metastasis for better patient selection and tailored treatment. The project is registered at http://www.ClinicalTrials.gov NCT01762813. BioMed Central 2016-06-29 /pmc/articles/PMC4928276/ /pubmed/27357108 http://dx.doi.org/10.1186/s12967-016-0951-4 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Protocol Søreide, Kjetil Watson, Martin M. Lea, Dordi Nordgård, Oddmund Søreide, Jon Arne Hagland, Hanne R. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis |
title | Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis |
title_full | Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis |
title_fullStr | Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis |
title_full_unstemmed | Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis |
title_short | Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis |
title_sort | assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (acrobaticc): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928276/ https://www.ncbi.nlm.nih.gov/pubmed/27357108 http://dx.doi.org/10.1186/s12967-016-0951-4 |
work_keys_str_mv | AT søreidekjetil assessmentofclinicallyrelatedoutcomesandbiomarkeranalysisfortranslationalintegrationincolorectalcanceracrobaticcstudyprotocolforapopulationbasedconsecutivecohortofsurgicallytreatedcolorectalcancersandresectedcolorectallivermetastasis AT watsonmartinm assessmentofclinicallyrelatedoutcomesandbiomarkeranalysisfortranslationalintegrationincolorectalcanceracrobaticcstudyprotocolforapopulationbasedconsecutivecohortofsurgicallytreatedcolorectalcancersandresectedcolorectallivermetastasis AT leadordi assessmentofclinicallyrelatedoutcomesandbiomarkeranalysisfortranslationalintegrationincolorectalcanceracrobaticcstudyprotocolforapopulationbasedconsecutivecohortofsurgicallytreatedcolorectalcancersandresectedcolorectallivermetastasis AT nordgardoddmund assessmentofclinicallyrelatedoutcomesandbiomarkeranalysisfortranslationalintegrationincolorectalcanceracrobaticcstudyprotocolforapopulationbasedconsecutivecohortofsurgicallytreatedcolorectalcancersandresectedcolorectallivermetastasis AT søreidejonarne assessmentofclinicallyrelatedoutcomesandbiomarkeranalysisfortranslationalintegrationincolorectalcanceracrobaticcstudyprotocolforapopulationbasedconsecutivecohortofsurgicallytreatedcolorectalcancersandresectedcolorectallivermetastasis AT haglandhanner assessmentofclinicallyrelatedoutcomesandbiomarkeranalysisfortranslationalintegrationincolorectalcanceracrobaticcstudyprotocolforapopulationbasedconsecutivecohortofsurgicallytreatedcolorectalcancersandresectedcolorectallivermetastasis AT assessmentofclinicallyrelatedoutcomesandbiomarkeranalysisfortranslationalintegrationincolorectalcanceracrobaticcstudyprotocolforapopulationbasedconsecutivecohortofsurgicallytreatedcolorectalcancersandresectedcolorectallivermetastasis |